一分钟看懂
这是一项关于Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer的III 期研究，登记的药物或干预包括zolbetuximab；Pembrolizumab；Capecitabine；Oxaliplatin；Folinic acid (leucovorin or local equivalent)；5-fluorouracil (5-FU)；Placebo，当前状态为招募中。登记地点显示中国合肥、福州、广州、哈尔滨等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
zolbetuximab；Pembrolizumab；Capecitabine；Oxaliplatin；Folinic acid (leucovorin or local equivalent)；5-fluorouracil (5-FU)；Placebo · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Anhui Provincial Cancer Hospital · 合肥
- Fujian Provincial Hospital - Department of Medical Oncology · 福州
- Sun Yat-sen University - Cancer Center · 广州
- Harbin Medical University Cancer Hospital - Oncology · 哈尔滨
- Henan Cancer Hospital - Oncology · 郑州
- Hubei Cancer Hospital - Oncology · 武汉
- Qinghai University Affiliated Hospital · 西宁
- Renji Hospital Shanghai Jiaotong Univ School of Medicine · 上海
- Ruijin Hospital of Shanghai Jiaotong University School of Medicine · 上海
- Sichuan Cancer Hospital · 成都
- Tianjin Medical University General Hospital · 天津
- The First Affiliated Hospital of Zhejiang University · 杭州
- Affiliated Hospital of Hebei University · 保定
- Peking Union Medical College Hospital - Dongdan Campus · 北京
公开的入选条件
- * Participant has histologically confirmed gastric or Gastroesophageal Junction (GEJ) adenocarcinoma.
- * Participant has radiographically confirmed, locally advanced, unresectable or metastatic disease within 28 days prior to randomization.
- * Participant has radiologically evaluable disease (measurable and/or nonmeasurable) according to Response Evaluation Criteria in Solid Tumors (RECIST) V1.1, ≤ 28 days prior to randomization. For participants with only 1 evaluable lesion and prior radiotherapy
- * Participant has Eastern Cooperative Oncology Group Performance Status (ECOG) performance status 0 to 1.
- * Participant has predicted life expectancy ≥ 12 weeks.
- * Participant must be a candidate to receive mFOLFOX6 or CAPOX and pembrolizumab.
- * Female participant is not pregnant and at least 1 of the following conditions apply:
- Not a woman of child bearing potential (WOCBP)
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06901531；登记信息更新于 2026-09-15。